Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
157 Citations•2021•
Sergio Vañó‐Galván, Rodrigo Pirmez, Ángela Hermosa‐Gelbard
LDOM has a good safety profile as a treatment for hair loss and systemic adverse effects were infrequent and only 1.7% of patients stopped the treatment due to adverse effects.
Abstract
LDOM has a good safety profile as a treatment for hair loss. Systemic adverse effects were infrequent and only 1.7% of patients discontinued treatment owing to adverse effects.